Market for immunosuppressant drugs to shrink dramatically? New obesity approach targeting fat cells effective in mouse model; Lyphoderm effective in treating enlarging leg ulcers; Stem cell update: controversy continues over ability to repair damagedtissues; Bayer testing IVIG for multiple sclerosis; Study backs Genemax's TAP-1 technology; Inamed brings botulinum toxin product one step closer to U.S. market.
展开▼
